Bilateral Meetings
- Thursday (1:30pm – 6:00pm)
- Friday (9:00am – 12:00pm)
Located at the Science Park in Leiden and with a staff of ten scientists, OcellO provides its drug screening services to many of the leading pharmaceutical companies as well as smaller biotech discovery companies in the Netherlands and worldwide.
Drug screening and profiling in cultured human (3D) tissues
We offer drug screening and profiling services for cancer and other diseases using cultured human (3D) tissues. Our screening platform combines throughput with histology grade automated imaging to discern both therapeutic and off-target/toxic effects in a biologically relevant context. From smaller biotech to big pharma and from large scale screens to profiling of a single lead molecule, our services provide rich information on the effects of your molecules, facilitating decision making
- Other
in vitro selection of PDX models for lead testing
- We offer in vitro PDX compound testing using tumour material derived from pre-clinical PDX mouse models.
- Identify the optimum drug - tumour model combination for pre-clinical studies.
- Save time, money and precious compound by testing your compounds in tumours cultured in microwell plates
- Other
Drug discovery collaborations
We seek companies that are developing small molecules and biologics for joint drug discovery collaborations. Partner and OcellO would contribute molecules and drug screening services respectively.
- Technical co-operation
Innovative 3D cell culture technologies
We particularly seek cooperation with companies developing hydrogels that may be suitable for 3D cell culture and enable replacement of animal derived hydrogel constituents.
As a CRO specialising in drug screening in 3D cell culture models, we present companies with an ideal opportunity to see their hydrogel technologies tried and tested and commercialised by a leading CRO in the 3D cell culture field.
- Technical co-operation